Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
program zdravljenja diseminiranega plazmocitoma
multiple myeloma program
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podporne študije novo diagnosticiranega diseminiranega plazmocitoma
supportive newly diagnosed multiple myeloma studies
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
načeloma diseminiranega plazmocitoma ni mogoče ozdraviti.
multiple myeloma generally cannot be cured.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
diseminiranega plazmocitoma na splošno ne moremo ozdraviti.
multiple myeloma generally cannot be cured.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ponovno zdravljenje bolnikov s ponovitvijo diseminiranega plazmocitoma
retreatment of patients with relapsed multiple myeloma
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
za zdravljenje diseminiranega plazmocitoma je bortezomib prejelo skupno 3.974 bolnikov.
overall, bortezomib was administered for the treatment of multiple myeloma in 3,974 patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
za zdravljenje diseminiranega plazmocitoma je zdravilo velcade prejelo skupno 3.974 bolnikov.
overall, velcade was administered for the treatment of multiple myeloma in 3,974 patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
izkazalo se je tudi, da zdravilo revlimid odloži ponovitev diseminiranega plazmocitoma po zdravljenju.
it has also been shown to delay multiple myeloma from coming back following treatment.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
diseminiranega plazmocitoma (rak kostnega mozga) pri bolnikih, starejših od 18 let:
multiple myeloma (a cancer of the bone marrow) in patients older than 18 years:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ko se zdravilo imnovid uporablja skupaj z deksametazonom, lahko ustavi poslabšanja diseminiranega plazmocitoma:
imnovid when used with dexamethasone can stop multiple myeloma getting worse:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kadar zdravilo revlimid uporabljamo za zdravljenje diseminiranega plazmocitoma, ga uporabljamo v kombinaciji z drugimi zdravili.
when used to treat multiple myeloma, revlimid is used in combination with other medicines.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
13 povzročil zmanjšanje rasti tumorja in vivo v mnogih predkliničnih tumorskih modelih, vključno z modelom diseminiranega plazmocitoma.
bortezomib causes reduction of tumour growth in vivo in many preclinical tumour models, including multiple myeloma.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
bortezomib je povzročil zmanjšanje rasti tumorja in vivo v mnogih predkliničnih tumorskih modelih, vključno z modelom diseminiranega plazmocitoma.
bortezomib causes reduction of tumour growth in vivo in many preclinical tumour models, including multiple myeloma.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
odmerjanje pri zdravljenju napredujočega diseminiranega plazmocitoma (bolniki, ki so pred tem že prejeli vsaj eno vrsto terapije)
posology for treatment of progressive multiple myeloma (patients who have received at least one prior therapy)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bortezomib se uporablja za zdravljenje diseminiranega plazmocitoma (rak kostnega mozga) pri bolnikih, starejših od 18 let:
bortezomib is used for the treatment of multiple myeloma (a cancer of the bone marrow) in patients older than 18 years:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zdravilo velcade se uporablja za zdravljenje diseminiranega plazmocitoma (rak kostnega mozga) pri bolnikih, starejših od 18 let:
velcade is used for the treatment of multiple myeloma (a cancer of the bone marrow) in patients older than 18 years:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ko se zdravilo imnovid uporablja skupaj z deksametazonom, v povprečju prepreči ponovitev diseminiranega plazmocitoma za do 16 tednov v primerjavi z 8 tedni pri bolnikih, ki uporabljajo samo deksametazon.
on average, imnovid when used with dexamethasone stopped multiple myeloma from coming back for up to 16 weeks compared with 8 weeks for those patients who used only dexamethasone.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
v kombinaciji z bortezomibom za zdravljenje napredovalega diseminiranega plazmocitoma pri bolnikih, ki so pred tem že prejeli najmanj eno vrsto predhodnega zdravljenja in so bodisi že imeli presaditev kostnega mozga ali pa niso primerni zanjo.
in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pomalidomid dodatno zavira proliferacijo celičnih vrst diseminiranega plazmocitoma, odpornih na lenalidomid, in v sinergiji z deksametazonom povzroči apoptozo tumorskih celic celičnih linij, občutljivih na lenalidomid in odpornih na lenalidomid.
additionally, pomalidomide inhibits the proliferation of lenalidomide-resistant multiple myeloma cell lines and synergises with dexamethasone in both lenalidomide-sensitive and lenalidomide-resistant cell lines to induce tumour cell apoptosis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daratumumab lahko zaznamo z elektroforezo serumskih proteinov in imunofiksacijo, ki se uporabljata za spremljanje monoklonskega imunoglobulina diseminiranega plazmocitoma (m-protein).
daratumumab may be detected on serum protein electrophoresis (spe) and immunofixation (ife) assays used for monitoring disease monoclonal immunoglobulins (m protein).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: